XLONCRW
Market cap972mUSD
Dec 24, Last price
2,215.00GBP
1D
-0.23%
1Q
1.61%
Jan 2017
67.17%
IPO
1,454.39%
Name
Craneware PLC
Chart & Performance
Profile
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 189,268 8.76% | 174,018 5.12% | 165,544 119.04% | |||||||
Cost of revenue | 35,133 | 32,334 | 96,413 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 154,135 | 141,684 | 69,131 | |||||||
NOPBT Margin | 81.44% | 81.42% | 41.76% | |||||||
Operating Taxes | 4,044 | 3,853 | 3,693 | |||||||
Tax Rate | 2.62% | 2.72% | 5.34% | |||||||
NOPAT | 150,091 | 137,831 | 65,438 | |||||||
Net income | 11,703 26.77% | 9,232 -1.88% | 9,409 -27.09% | |||||||
Dividends | (12,798) | (12,119) | (12,976) | |||||||
Dividend yield | 1.57% | 2.51% | 1.99% | |||||||
Proceeds from repurchase of equity | (3,072) | (3,856) | (3,216) | |||||||
BB yield | 0.38% | 0.80% | 0.49% | |||||||
Debt | ||||||||||
Debt current | 8,952 | 9,389 | 8,000 | |||||||
Long-term debt | 35,970 | 80,958 | 106,581 | |||||||
Deferred revenue | 958 | 2,875 | 104,157 | |||||||
Other long-term liabilities | 34,149 | 243 | (103,589) | |||||||
Net debt | 10,333 | 11,810 | 67,424 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 41,862 | 98,748 | 26,964 | |||||||
CAPEX | (1,191) | (15,551) | (14,033) | |||||||
Cash from investing activities | (15,814) | (15,337) | (307,320) | |||||||
Cash from financing activities | (69,996) | (53,282) | 91,896 | |||||||
FCF | 188,238 | 142,215 | 59,171 | |||||||
Balance | ||||||||||
Cash | 34,589 | 78,537 | 47,157 | |||||||
Long term investments | ||||||||||
Excess cash | 25,126 | 69,836 | 38,880 | |||||||
Stockholders' equity | 235,880 | 368,385 | 375,917 | |||||||
Invested Capital | 379,678 | 345,248 | 407,795 | |||||||
ROIC | 41.41% | 36.61% | 33.86% | |||||||
ROCE | 38.17% | 31.04% | 13.99% | |||||||
EV | ||||||||||
Common stock shares outstanding | 35,292 | 35,435 | 35,477 | |||||||
Price | 23.10 69.23% | 13.65 -25.82% | 18.40 -13.62% | |||||||
Market cap | 815,245 68.55% | 483,688 -25.90% | 652,777 12.73% | |||||||
EV | 825,578 | 629,509 | 860,300 | |||||||
EBITDA | 187,518 | 173,846 | 98,534 | |||||||
EV/EBITDA | 4.40 | 3.62 | 8.73 | |||||||
Interest | 5,130 | 6,357 | 5,031 | |||||||
Interest/NOPBT | 3.33% | 4.49% | 7.28% |